BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative oncology and rare disease treatments. The company is set to release its Q1 2026 financial results...
SANUWAVE Health, Inc. currently faces financial c...
Elbit Systems (NASDAQ: ESLT) anticipates sign...
Jefferies initiated a "Hold" rating on Pershing Square (NYSE: PS) with a $40.00 price target, suggesting a potential 12.14% upside from its current price. Activist investor Bill Ackman's fund
Futu Holdings (NASDAQ: FUTU), a leading online brokerage, received a downgrade to Neutral from Goldman Sachs, with a new price target of $102.13. The downgrade is linked to a China Securities Regulat
BMO Capital maintains an "Outperform" rating for Lightspeed Commerce but has lowered its price target, indicating a mixed outlook. Despite strong revenue performance, Lightspeed Commerce face
AutoZone (NYSE: AZO) is set to report strong quarterly earnings, with projected EPS of $36.22 and revenues of $4.86 billion. Analyst sentiment is highly positive, with a Zacks Rank #2 (Buy) a
Permian Resources (NYSE:PR) Navigates Price Target Adjustment Amid Strong Operational Performance Despite a lowered price target from Wells Fargo (NYSE:WFC), Permian Resources (NYSE:PR) demonstrates
Investment firm Goldman Sachs downgraded Futu Holdings (NASDAQ:FUTU) from Buy to Neutral. The downgrade follows a China Securities Regulatory Commission (CSRC) investigation into Futu Holding